Research ArticleCardiovascular
Inhibition of Extracellular Cyclophilins with Cyclosporine Analog and Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
Michael Ditiatkovski, Vijaya N. L. V. Neelisetti, Huanhuan L. Cui, Miroslav Malesevic, Gunter Fischer, Michael Bukrinsky and Dmitri Sviridov
Journal of Pharmacology and Experimental Therapeutics June 2015, 353 (3) 490-495; DOI: https://doi.org/10.1124/jpet.115.223420
Michael Ditiatkovski
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Vijaya N. L. V. Neelisetti
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Huanhuan L. Cui
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Miroslav Malesevic
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Gunter Fischer
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Michael Bukrinsky
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Dmitri Sviridov
Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia (M.D., V.N.L.V.N., H.L.C., D.S.); Department of Biochemistry, Martin Luther University of Halle-Wittenberg, Halle (Saale), Germany (M.M.); Max Planck Institute for Biophysical Chemistry, Gottingen, Germany (G.F.); and Department of Microbiology, and Immunology and Tropical Medicine, George Washington University, Washington, DC (M.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
Extracellular Cyclophilins and Atherosclerosis
Michael Ditiatkovski, Vijaya N. L. V. Neelisetti, Huanhuan L. Cui, Miroslav Malesevic, Gunter Fischer, Michael Bukrinsky and Dmitri Sviridov
Journal of Pharmacology and Experimental Therapeutics June 1, 2015, 353 (3) 490-495; DOI: https://doi.org/10.1124/jpet.115.223420
Research ArticleCardiovascular
Extracellular Cyclophilins and Atherosclerosis
Michael Ditiatkovski, Vijaya N. L. V. Neelisetti, Huanhuan L. Cui, Miroslav Malesevic, Gunter Fischer, Michael Bukrinsky and Dmitri Sviridov
Journal of Pharmacology and Experimental Therapeutics June 1, 2015, 353 (3) 490-495; DOI: https://doi.org/10.1124/jpet.115.223420
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement